BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish ...
Illumina Inc. (Nasdaq: ILMN), a genomics and molecular diagnostics company headquartered in San Diego, closed in late January on its acquisition of Boulder-based biotech firm SomaLogic Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), today announced that the SomaScan ® 11K Platform now includes protein measurements on a broader ...
While it may not be enough for some shareholders, we think it is good to see the Standard BioTools Inc. (NASDAQ:LAB) share price up 14% in a single quarter. But that doesn't change the fact that the ...
SomaLogic Inc.’s SLGC stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with Standard ...
CEO Michael Egholm highlighted that Standard BioTools delivered Q1 2025 revenues of $40.8 million, aligned with their plan despite a challenging operating backdrop. He emphasized improvements in ...
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced ...
LOS ANGELES--(BUSINESS WIRE)--BioTools Innovator, a new accelerator program developed by the team behind MedTech Innovator, the world’s largest accelerator of medical device startups, announced its ...
The Dow Jones index closed higher by around 0.2% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders ...
LOS ANGELES--(BUSINESS WIRE)--BioTools Innovator, the first-ever accelerator focused on life science tools companies, announced today that GenNext Technologies is the grand prize winner of the ...
Received $350 Million in upfront cash at closing; Up to $425 Million in total proceeds inclusive of near-term earnout payments Approximately $550 Million in cash & cash equivalents on balance sheet at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results